Abstract |
The alkyl-linked lipoidal amine 4-aminomethyl-1-[2,3-(di-n-decyloxy)-n-propyl]-4-phenylpiperidine (CP-46,665) was tested for therapeutic activity in 2 rodent tumor models and 2 human non-seminomatous germ cell tumors growing in nude mice. CP-46,665 failed to show therapeutic efficacy in 3-Lewis lung carcinoma (3-LL) growing in syngeneic C57Bl6-mice, in methylnitrosourea (MNU)-induced rat mammary carcinomas and in 2 human non-seminomatous germ cell tumor cell lines (H 12.1, H 12.7) growing in nu/nu NMRI-mice when given in a dose range including non-toxic doses and doses higher than the lethal dose for 10% of the treated animals (LD10).
|
Authors | W E Berdel, M R Berger, H Falk, A Harstrick, S Danhauser, H D Schick, H J Schmoll, D Schmähl, W R Vogler, J Rastetter |
Journal | Cancer letters
(Cancer Lett)
Vol. 38
Issue 1-2
Pg. 191-7
(Dec 1987)
ISSN: 0304-3835 [Print] Ireland |
PMID | 2825966
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Antineoplastic Agents
- Piperidines
- CP 46665
|
Topics |
- Animals
- Antineoplastic Agents
(therapeutic use)
- Female
- Humans
- Mammary Neoplasms, Experimental
(drug therapy)
- Mice
- Mice, Inbred C57BL
- Mice, Nude
- Neoplasm Transplantation
- Neoplasms, Experimental
(drug therapy)
- Neoplasms, Germ Cell and Embryonal
(drug therapy)
- Piperidines
(therapeutic use)
- Rats
- Rats, Inbred Strains
- Transplantation, Heterologous
|